Study of a Pandemic Influenza Vaccine in Children

Seqirus220 enrolled

Overview

The World Health Organisation has warned that an influenza pandemic is inevitable. The avian influenza strain H5N1 is one of the leading candidates to cause the next influenza pandemic. Children are likely to be a special target group for vaccination; therefore, this study will test the safety and immunogenicity of an H5N1 pandemic influenza vaccine in healthy children.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

PREVENTION

Masking

DOUBLE

Enrollment

220

Conditions

Influenza

Interventions

H5N1 pandemic influenza vaccineBIOLOGICAL

Eligibility

Sex: ALLMin age: 6 MonthsMax age: 8 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * Healthy children aged greater or equal to 6 months to less than 9 years * Normal gestation period Exclusion Criteria: * History of clinically significant medical conditions * History of Guillain Barre syndrome or active neurological disease

Locations (2)

Murdoch Childrens Research Institute

Melbourne, Victoria, Australia

Princess Margaret Hospital for Children

Perth, Western Australia, Australia

Outcomes

Primary Outcomes

Safety and immunogenicity

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.